Investigating the Efficacy of Sleepgift Blanket on Sleep Quality and Heart Health

Last updated: March 31, 2025
Sponsor: University of Manitoba
Overall Status: Completed

Phase

1

Condition

N/A

Treatment

Active sleepgift blanket

Sham Sleepgift Blanket

Clinical Study ID

NCT05463302
Sleep Gift Blanket
  • Ages 18-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Exposure to electromagnetic field (EMF) emitted by mobile phones and devices with WIFI is on the rise and so is the EMF effects on sleep quality and well-being of individuals with high exposures to EMF. Some studies have shown poor sleep quality among individuals with long-term occupational exposure to EMF, and some have shown association between EMF long-term exposure and neuropsychiatric disorders including depression. This study aims to investigate a commercially available EMF- blocker blanket, called Sleepgift, that claims helping people to have a better sleep and improved health. We will investigate the Sleepgift efficacy on adults' quality of sleep and their vital signals as a measure of their well-being in a placebo-controlled single- blind cross-over designed study. Participants will sleep in our sleep lab at baseline and then 10 days later with the Sleepgift blanket after using it every night for the past 10 consecutive days. Participants will be given two blankets for each cycle of the study as it is a cross-over designed study: one Sleepgift and one regular blanket; they will not know which one is real or sham. There will be one-month washout period between the two cycles of the cross-over study. We aim to enroll 30 adults for the study. Participants' sleep quality will be measured by the established device called Prodogy; their vital signals will also be measured and monitored through the night. The collected data will be analyzed statistically for any significant effect of the Sleepgift blanket on sleep quality and vital signals such as heart's rhythm and heart rate variability.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 y<age<70 years

  • Being generally healthy (cognitively and psychologically)

  • ability to read, write and speak English fluently.

Exclusion

Exclusion Criteria:

  • Being diagnosed with any neurological, intellectual disability, majordepression/anxiety, bipolar disorder, schizophrenia or any other major mooddisorder.

  • Inability to adequately communicate in English

  • Current substance abuse disorder

  • Currently participating in another therapeutic study

  • Being on a regular pain killer, sleeping or depression pill.

Study Design

Total Participants: 31
Treatment Group(s): 2
Primary Treatment: Active sleepgift blanket
Phase: 1
Study Start date:
January 01, 2023
Estimated Completion Date:
October 11, 2024

Connect with a study center

  • Riverview Health Center

    Winnipeg, Manitoba R3L 2P4
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.